These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049 [TBL] [Abstract][Full Text] [Related]
25. IL-33-PU.1 Transcriptome Reprogramming Drives Functional State Transition and Clearance Activity of Microglia in Alzheimer's Disease. Lau SF; Chen C; Fu WY; Qu JY; Cheung TH; Fu AKY; Ip NY Cell Rep; 2020 Apr; 31(3):107530. PubMed ID: 32320664 [TBL] [Abstract][Full Text] [Related]
26. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease. Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227 [TBL] [Abstract][Full Text] [Related]
27. Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk. Efthymiou AG; Goate AM Mol Neurodegener; 2017 May; 12(1):43. PubMed ID: 28549481 [TBL] [Abstract][Full Text] [Related]
32. IGF1R and FLT1 in female endothelial cells and CHD2 in male microglia play important roles in Alzheimer's disease based on gender difference analysis. He R; Cheng J; Qiu Y; Hu Y; Liu J; Wang TH; Cao X Exp Gerontol; 2024 Sep; 194():112512. PubMed ID: 38971545 [TBL] [Abstract][Full Text] [Related]
33. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model. Wang H; Li Y; Ryder JW; Hole JT; Ebert PJ; Airey DC; Qian HR; Logsdon B; Fisher A; Ahmed Z; Murray TK; Cavallini A; Bose S; Eastwood BJ; Collier DA; Dage JL; Miller BB; Merchant KM; O'Neill MJ; Demattos RB Mol Neurodegener; 2018 Dec; 13(1):65. PubMed ID: 30558641 [TBL] [Abstract][Full Text] [Related]
34. Microglia - mediated immunity partly contributes to the genetic association between Alzheimer's disease and hippocampal volume. Lancaster TM; Hill MJ; Sims R; Williams J Brain Behav Immun; 2019 Jul; 79():267-273. PubMed ID: 30776473 [TBL] [Abstract][Full Text] [Related]
36. The involvement of microglia in Alzheimer's disease: a new dog in the fight. Moore Z; Taylor JM; Crack PJ Br J Pharmacol; 2019 Sep; 176(18):3533-3543. PubMed ID: 30445661 [TBL] [Abstract][Full Text] [Related]
37. Reduced TREM2 activation in microglia of patients with Alzheimer's disease. Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252 [TBL] [Abstract][Full Text] [Related]
39. Network dynamics-based subtyping of Alzheimer's disease with microglial genetic risk factors. Choi JH; Lee J; Kang U; Chang H; Cho KH Alzheimers Res Ther; 2024 Oct; 16(1):229. PubMed ID: 39415193 [TBL] [Abstract][Full Text] [Related]
40. The interplay between microglial states and major risk factors in Alzheimer's disease through the eyes of single-cell RNA-sequencing: beyond black and white. von Maydell D; Jorfi M J Neurophysiol; 2019 Oct; 122(4):1291-1296. PubMed ID: 31365320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]